DURANEST Drug Patent Profile
✉ Email this page to a colleague
When do Duranest patents expire, and what generic alternatives are available?
Duranest is a drug marketed by Astrazeneca and Dentsply Pharm and is included in two NDAs.
The generic ingredient in DURANEST is etidocaine hydrochloride. Additional details are available on the etidocaine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DURANEST?
- What are the global sales for DURANEST?
- What is Average Wholesale Price for DURANEST?
Summary for DURANEST
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Patent Applications: | 4,326 |
DailyMed Link: | DURANEST at DailyMed |
US Patents and Regulatory Information for DURANEST
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astrazeneca | DURANEST | epinephrine; etidocaine hydrochloride | INJECTABLE;INJECTION | 017751-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Astrazeneca | DURANEST | etidocaine hydrochloride | INJECTABLE;INJECTION | 017751-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Astrazeneca | DURANEST | epinephrine bitartrate; etidocaine hydrochloride | INJECTABLE;INJECTION | 017751-006 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Astrazeneca | DURANEST | epinephrine bitartrate; etidocaine hydrochloride | INJECTABLE;INJECTION | 017751-007 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Dentsply Pharm | DURANEST | epinephrine bitartrate; etidocaine hydrochloride | INJECTABLE;INJECTION | 021384-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DURANEST
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astrazeneca | DURANEST | etidocaine hydrochloride | INJECTABLE;INJECTION | 017751-005 | Approved Prior to Jan 1, 1982 | ⤷ Subscribe | ⤷ Subscribe |
Astrazeneca | DURANEST | etidocaine hydrochloride | INJECTABLE;INJECTION | 017751-005 | Approved Prior to Jan 1, 1982 | ⤷ Subscribe | ⤷ Subscribe |
Astrazeneca | DURANEST | epinephrine bitartrate; etidocaine hydrochloride | INJECTABLE;INJECTION | 017751-007 | Approved Prior to Jan 1, 1982 | ⤷ Subscribe | ⤷ Subscribe |
Astrazeneca | DURANEST | etidocaine hydrochloride | INJECTABLE;INJECTION | 017751-005 | Approved Prior to Jan 1, 1982 | ⤷ Subscribe | ⤷ Subscribe |
Astrazeneca | DURANEST | epinephrine; etidocaine hydrochloride | INJECTABLE;INJECTION | 017751-004 | Approved Prior to Jan 1, 1982 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DURANEST
See the table below for patents covering DURANEST around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 139814 | ⤷ Subscribe | |
Australia | 468489 | ⤷ Subscribe | |
Italy | 1066334 | COMPOSIZIONE AN ESTETICA LOCALE DELLA 2-ALCHIL-2-ALCHIL AMMINO 2',6' ACETOSSILIDIDE E RELATIVO PROCEDIMENTO DI PRODUZIONE | ⤷ Subscribe |
Finland | 55027 | ⤷ Subscribe | |
Netherlands | 8204126 | ⤷ Subscribe | |
>Country | >Patent Number | >Title | >Estimated Expiration |